← Back
Data updated: Mar 10, 2026
XTTRIUM
Dermatology
XTTRIUM is a specialty pharmaceutical company focused on Dermatology.
1984
Since
5
Drugs
-
Trials
81
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
EXIDINE 2026-02-03
Labeling
EXIDINE 2026-02-03
Manufacturing (CMC)
PREDNISONE 2025-10-01
CLINDAMYCIN PHOSPHATE 2025-08-22
Labeling
CLINDAMYCIN PHOSPHATE 2025-08-22
Labeling
CLINDAMYCIN PHOSPHATE 2025-08-22
Labeling
CLINDAMYCIN PHOSPHATE 2025-08-22
Labeling
CLINDAMYCIN PHOSPHATE 2025-08-22
Labeling
CLINDAMYCIN PHOSPHATE 2025-08-22
Labeling
CLINDAMYCIN PHOSPHATE 2025-08-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (4)
Company Info
- First Approval
- 1984-12-24
- Latest
- 2026-02-03
- Applications
- 9
FDA Sponsor Names
XTTRIUMXTTRIUM LABS INC